Citation Impact
Citing Papers
The HER-2 Receptor and Breast Cancer: Ten Years of Targeted Anti–HER-2 Therapy and Personalized Medicine
2009
Trastuzumab Emtansine for HER2-Positive Advanced Breast Cancer
2012 Standout
Target-based agents against ErbB receptors and their ligands: a novel approach to cancer treatment.
2003
Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial
2010 Standout
Gastric cancer
2016 Standout
EGFR and cancer prognosis
2001 Standout
EGFR Antagonists in Cancer Treatment
2008 Standout
Pancreatic cancer
2004 Standout
Cellular and Gene Expression Responses Involved in the Rapid Growth Inhibition of Human Cancer Cells by RNA Interference-mediated Depletion of Telomerase RNA
2005 StandoutNobel
Hyperthermia in combined treatment of cancer
2002 Standout
Clinical utility of telomerase in cancer
2002
Phytoestrogens — a short review
1995
Genetic alterations in human gastrointestinal cancers. The application to molecular diagnosis
1995
Oncogenic kinase signalling
2001 StandoutNature
Molecular Biology of Barrett’s Adenocarcinoma
2001
Helicobacter pylori infection triggers aberrant expression of activation-induced cytidine deaminase in gastric epithelium
2007 StandoutNobel
Molecular mechanisms of epithelial–mesenchymal transition
2014 Standout
Heating the patient: a promising approach?
2002 Standout
Cell Signaling by Receptor Tyrosine Kinases
2010 Standout
hEST2, the Putative Human Telomerase Catalytic Subunit Gene, Is Up-Regulated in Tumor Cells and during Immortalization
1997 Standout
The Clinical Significance of Epidermal Growth Factor Receptor (EGF-R) in Human Breast Cancer: A Review on 5232 Patients*
1992
Identification of DFNA5 as a target of epigenetic inactivation in gastric cancer
2006
Head and neck cancer
2008 Standout
The Protective Effects of Estrogen on the Cardiovascular System
1999 Standout
Distant metastasis occurs late during the genetic evolution of pancreatic cancer
2010 StandoutNature
Gene deregulation in gastric cancer
2005
Esophageal Cancer
2003 Standout
Telomere Shortening and Tumor Formation by Mouse Cells Lacking Telomerase RNA
1997 StandoutNobel
Chemotherapy for advanced gastric cancer
2010
The Hallmarks of Cancer
2000 Standout
Human Cancer Cells Harbor T-Stumps, a Distinct Class of Extremely Short Telomeres
2007 StandoutNobel
EGF–ERBB signalling: towards the systems level
2006 Standout
Role of the retinoblastoma protein in the pathogenesis of human cancer.
1997 StandoutNobel
Salvia miltiorrhiza inhibits cell growth and induces apoptosis in human hepatoma HepG2 cells
2000
Telomere dysfunction and the initiation of genome instability
2003 StandoutNobel
Hyperthermia in oncology
2001
Combined suicide gene therapy for pancreatic peritoneal carcinomatosis using BGTC liposomes
2003
Clinical resistance to topoisomerase-targeted drugs
1998
Emerging molecular markers of cancer
2002
STATs in oncogenesis
2000 Standout
Left thoracoabdominal approach versus abdominal-transhiatal approach for gastric cancer of the cardia or subcardia: a randomised controlled trial
2006
Invited Review: For the clinical application of thermochemotherapy given at mild temperatures
1999
Genome maintenance mechanisms for preventing cancer
2001 StandoutNature
A survey of telomerase activity in human cancer
1997 Standout
Cytokine Signaling in 2002
2002 Standout
Pertuzumab plus Trastuzumab plus Docetaxel for Metastatic Breast Cancer
2011 Standout
Erlotinib in Lung Cancer — Molecular and Clinical Predictors of Outcome
2005 Standout
Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan
2003 StandoutNature
Creation of human tumour cells with defined genetic elements
1999 StandoutNature
Genetic Alterations of Cyclins, Cyclin-Dependent Kinases, and Cdk Inhibitors in Human Cancer
1996
Head and Neck Cancer
2001 Standout
Chemotherapy drugs induce pyroptosis through caspase-3 cleavage of a gasdermin
2017 StandoutNature
Matrix Metalloproteinases: Biologic Activity and Clinical Implications
2000
Constituents from Salvia Species and Their Biological Activities
2012 Standout
Fluorine in Pharmaceutical Industry: Fluorine-Containing Drugs Introduced to the Market in the Last Decade (2001–2011)
2013 Standout
Coordinating Radiometals of Copper, Gallium, Indium, Yttrium, and Zirconium for PET and SPECT Imaging of Disease
2010 Standout
Telomerase extends the lifespan of virus-transformed human cells without net telomere lengthening
1999 StandoutNobel
Clinical Studies of Three Oral Prodrugs of 5-Fluorouracil (Capecitabine, UFT, S-1): A Review
2002
Telomerase activity, cell proliferation, and cancer
1998 StandoutNobel
Cancer Cell Cycles
1996 StandoutScience
The rate of telomere sequence loss in human leukocytes varies with age
1998 StandoutNobel
Genes and pathways downstream of telomerase in melanoma metastasis
2006 StandoutNobel
Phase I study of topoisomerase I inhibitor exatecan mesylate (DX-8951f) given as weekly 24-hour infusions three of every four weeks.
2001
Role of Cripto-1 during Epithelial-to-Mesenchymal Transition in Development and Cancer
2012
Phytoestrogens: epidemiology and a possible role in cancer protection.
1995 Standout
Esophageal Cancer: Associated Factors with Special Reference to the Kashmir Valley
2012
Telomerase Catalytic Subunit Homologs from Fission Yeast and Human
1997 StandoutScienceNobel
The HER-2/neu Gene and Protein in Breast Cancer 2003: Biomarker and Target of Therapy
2003
The Effects of Plant Flavonoids on Mammalian Cells:Implications for Inflammation, Heart Disease, and Cancer
2000 Standout
Nucleic Acid-Based Methods for the Detection of Cancer
1997 Science
Matrix Metalloproteinase Inhibitors and Cancer—Trials and Tribulations
2002 StandoutScience
Targeted Delivery of mRNA with One-Component Ionizable Amphiphilic Janus Dendrimers
2021 StandoutNobel
The cyclin D1 gene is a target of the β-catenin/LEF-1 pathway
1999 Standout
p53 Alterations Predict Tumor Response to Neoadjuvant Chemotherapy in Head and Neck Squamous Cell Carcinoma: A Prospective Series
2000
Overview of epidermal growth factor receptor biology and its role as a therapeutic target in human neoplasia
2002
Global cancer statistics, 2012
2015 Standout
Structural Basis of Type II Topoisomerase Inhibition by the Anticancer Drug Etoposide
2011 StandoutScience
Works of T Toge being referenced
Immunocytochemical and biochemical analysis of epidermal growth factor receptor expression in human breast cancer tissues: Relationship to estrogen receptor and lymphatic invasion
1989
p53, p21(Waf1/Cip1) and cyclin D1 protein expression and prognosis in esophageal cancer *
1999
A Randomized Phase II Clinical Trial of Tailored CPT-11 + S-1 vs S-1 in Patients with Advanced or Recurrent Gastric Carcinoma as the First Line Chemotherapy
2004
Detection of telomerase activity in exfoliated cancer cells in colonic luminal washings and its related clinical implications
1997
Enhancement of antitumor effect by intratumoral administration of bax gene in combination with anticancer drugs in gastric cancer
2001
Clinical results of transhiatal esophagectomy for carcinoma of the lower thoracic esophagus according to biological markers
1998
Expression of MDR1, GST-pi and topoisomerase II as an indicator of clinical response to adriamycin.
1991
COAMPLIFICATION OF CYCLIN-D, HST-1 AND INT-2 GENES IS A GOOD BIOLOGICAL MARKER OF HIGH MALIGNANCY FOR HUMAN ESOPHAGEAL CARCINOMAS
1994
Antiproliferative effects of isoflavones on human cancer cell lines established from the gastrointestinal tract.
1993
Expression and relationship between topoisomerase I and II alpha genes in tumor and normal tissues in esophageal, gastric and colon cancers.
2000
Chemotherapy combined with or without hyperthermia for patients with oesophageal carcinoma: a prospective randomized trial
1994
The role of HER-2 oncoprotein in drug-sensitivity in breast cancer (Review)
2002
[A new therapeutic approach to advanced and recurrent gastric cancer by TS-1].
2001
Effects of surgical stress on natural killer activity, proliferative response of spleen cells and cytostatic activity of lung macrophages in rats.
1981
Dihydropyrimidine dehydrogenase, multidrug resistance-associated protein, and thymidylate synthase gene expression levels can predict 5-fluorouracil resistance in human gastrointestinal cancer cells.
1999
Stromelysin-3 mRNA expression and malignancy: comparison with clinicopathological features and type IV collagenase mRNA expression in breast tumors.
1994
IMMUNOHISTOCHEMICAL DETECTION OF CRIPTO-1, AMPHIREGULIN AND TRANSFORMING GROWTH-FACTOR-ALPHA IN HUMAN GASTRIC CARCINOMAS AND INTESTINAL METAPLASIAS
1994